The AI model that is changing clinical trial design
Drug Target Review
JULY 1, 2025
Clinical trials are expensive, slow and often limited by outdated design constraints. They offer patient-specific outcome predictions, generated using machine learning models trained on real historical clinical data. Digital twins offer a way forward. Unlearn is one of the few companies applying this approach at scale.
Let's personalize your content